about
Bone metabolism in children and adolescents: main characteristics of the determinants of peak bone massBone status in genetic syndromes: a reviewBone mass and quality in patients with juvenile idiopathic arthritis: longitudinal evaluation of bone-mass determinants by using dual-energy x-ray absorptiometry, peripheral quantitative computed tomography, and quantitative ultrasonography.CYP19 and ESR1 gene polymorphisms: response of the bone mineral density in post-menopausal women to hormonal replacement therapyThe ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment.The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the "Knudson's second hit"Connections between the outcomes of osteoporotic hip fractures and depression, delirium or dementia in elderly patients: rationale and preliminary data from the CODE studySevere osteoporosis: diagnosis of non-hip non-vertebral (NHNV) fractures.Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin.Compliance to antifracture treatments in Tuscany: a regional survey based on institutional pharmaceutical dataset.Targeted approaches in the treatment of osteoporosis: differential mechanism of action of denosumab and clinical utility.Bone health in children and adolescents: the available imaging techniques.Fracture unit: a (possible) model of implementation in Italy.Parathyroid Hormone Levels in Healthy Children and Adolescents.Bone Status in a Patient with Insulin-Like Growth Factor-1 Receptor Deletion Syndrome: Bone Quality and Structure Evaluation Using Dual-Energy X-Ray Absorptiometry, Peripheral Quantitative Computed Tomography, and Quantitative Ultrasonography.Biological effects of dosing aerobic exercise and neuromuscular electrical stimulation in rats.Osteonecrosis of the jaw in a patient with rheumatoid artritis treated with an oral aminobisphosphonate: a clinical case report.Aging of the skeletal muscle extracellular matrix drives a stem cell fibrogenic conversion.Cross-sectional and longitudinal evaluation of bone mass and quality in children and young adults with juvenile onset systemic lupus erythematosus (JSLE): role of bone mass determinants analyzed by DXA, PQCT and QUS.Comparison of bone mass and quality determinants in adolescents and young adults with juvenile systemic lupus erythematosus (JSLE) and juvenile idiopathic arthritis (JIA).P9 - A Novel Mutation of the PHEX Gene in a Family with Hypophosphataemic Rickets.Bone Metabolism Disorders in Patients with Spinal Cord Injuries.P28 - Calcific Tendinopathy and Vitamin D Status: A Potential Aetiopathogenetic Factor and Therapeutic Approach.P8 - Measurement of Fibroblast Growth Factor-23 (FGF23) in the Serum of Patients Affected by Juvenile Systemic Lupus Erythematosus: A Possible Marker of Kidney Damage.The Fracture Unit Model. A Model for Implementation in Italy: “Multidisciplinary Approach for the Prevention and Treatment of Osteoporotic Vertebral Compression Fractures: VCF Unit”.The “Bone Care Nurse” Project.Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre group.Thyroid function in Rett syndrome.Role of Acupuncture in the Management of Severe Acquired Brain Injuries (sABIs)Comparison of bone mass and quality determinants in adolescents and young adults with juvenile systemic lupus erythematosus (JSLE) and juvenile idiopathic arthritis (JIA)A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemiaRadiofrequency echographic multispectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neckRadiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis a
P50
Q26996397-8BAFEE59-2F32-4326-A492-9D1C35AD44A1Q28085314-5B132D40-483F-4303-95BC-6BE46EB5A66CQ33766649-63ED0885-69ED-479C-88CF-B5B94828FAEBQ33781613-F71FF566-5B35-4C6D-B39D-96AB2CDB6B2FQ33781943-3E21AE6A-DA35-4BE8-ACCC-58F036E99098Q34326504-D95D74E6-A509-41E0-9B63-784494F3FFD0Q34333068-E65DA95A-9AEA-40E1-92BE-94893065ACB7Q34417165-50F3BBE0-10B7-4174-ADE5-81311810F284Q34447002-39A65CB6-F7C2-4955-A956-13A262C46CA9Q35755661-40A8A7BA-1343-45C0-9972-4FF578946AD1Q36058895-1B7F2A6B-B3CA-4D9D-A62E-60032778F3FFQ37567191-43E6900D-9B3D-45E3-8E1D-1B574B50CE51Q39610200-14EEC099-B551-4B80-A0B9-28E45E7AE74EQ40773215-FEDA96E5-D53A-4D30-9C24-E82842209710Q41238081-9FA669A4-D2F7-4181-8424-BB9E951DFA4AQ41544101-8B147233-C3E6-45B8-A49A-5BED76B5A209Q41944364-81BF4DF8-63BC-47D0-BA97-68CD3E151083Q42252666-DE068677-BAA1-4717-A95A-82360E7E25C4Q44022058-70843BD6-6509-4540-AA66-49001E417AE4Q44676350-95AE0A8A-8070-426A-9220-94E1EA7E1FFCQ45849548-F8A14549-6061-4E53-9C49-7D3CA748BB5DQ45849581-311F33AD-5F5A-426A-9552-5308E8A488B4Q45849642-234A69AC-407E-42C7-87DD-709516436F62Q45849671-4F07C2CF-42D6-4CD7-A087-F97BD77AE8C2Q45849889-ADE18C0A-9849-48B0-84B3-10AA64175EE6Q45849996-FE1272B0-FEDD-4F12-A204-FCDF4AFC6718Q45859429-9EB58555-0FF4-4BE4-8760-45EF5A68635EQ48364148-D3738521-8688-49A5-A746-B33B2767CBCBQ57300451-1E700651-E33D-45A4-8679-6F5A6EE4B8E7Q57927151-AAC92D4A-D7CE-48B1-8E6A-1154D668803BQ60679646-61F02705-4CBD-460D-B772-06C77BA4A510Q91277873-E216B2EE-4EEF-4288-AF4C-0A6A1386683EQ92679842-B3C50C7D-8876-46B7-8C2A-76AA9E4AD453
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
L Cavalli
@ast
L Cavalli
@en
L Cavalli
@es
L Cavalli
@nl
L Cavalli
@sl
type
label
L Cavalli
@ast
L Cavalli
@en
L Cavalli
@es
L Cavalli
@nl
L Cavalli
@sl
prefLabel
L Cavalli
@ast
L Cavalli
@en
L Cavalli
@es
L Cavalli
@nl
L Cavalli
@sl
P106
P1153
26644814300
P31
P496
0000-0003-4075-933X